Premium
The spectroscopic properties of the lipodepsipeptide, syringomycin E
Author(s) -
Vaillo Eva,
Ballo Alessandro,
Luisi PierLuigi,
Thomas Richard M.
Publication year - 1992
Publication title -
biopolymers
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.556
H-Index - 125
eISSN - 1097-0282
pISSN - 0006-3525
DOI - 10.1002/bip.360321006
Subject(s) - chemistry , residue (chemistry) , absorbance , dipeptide , stereochemistry , solvent , cyclic peptide , peptide , organic chemistry , chromatography , biochemistry
The Spectroscopic properties of syringomycin E, an antibiotic lipodepsinonapeptide associated with pathological states in plants, have been investigated by uv absorbance and CD spectroscopies, and by the synthesis of relevant model compounds. Initial studies [E. Vaillo, A. Ballio, P. L. Luisi, and R. M. Thomas (1990) in Peptides 1990 , Giralt, E. & Andreu, D., Eds., Escom Scientific, Leiden, Netherlands] suggested that a significant contribution to the spectra was due to the presence of a z dehydroaminobutyric acid residue in the amino acid sequence. The model peptides N‐Boc‐ L ‐Phe‐Δ Z Abu‐OMe and its analogue, N‐Boc‐ L ‐Phe‐ L ‐Thr‐OMe, lacking the unsaturated bond, were synthesized using standard solution chemistry, and a detailed investigation was made in which the spectra of the models and that of syringotoxin (an antibiotic closely related to syringomycin E but without a Phe residue) were compared with those of syringomycin E under a variety of solvent conditions. The uv absorbance spectra of both N‐Boc‐ L ‐Phe‐Δ Z Abu‐OMe and syringomycin E clearly showed the presence of the unsaturated residue while the CD spectra were complex, environmentally sensitive, and contained contributions from both the Δ z Abu and Phe residues. In the course of these studies extinction coefficients were obtained for syringomycin E and its dipeptide model. The origins of the uv and CD spectra are discussed in detail, and a comparison is made with the spectra of other, similar lipopeptide antibiotics. Finally, a structural model for syringomycin is proposed in which the changes induced in the spectrum by alterations in the solvent environment are accommodated. © 1992 John Wiley & Sons, Inc.